OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Therapeutics is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?	118
Antibiotic Stewardship in Food-producing Animals: Challenges, Progress, and Opportunities	83
Stress-induced Interaction of Skin Immune Cells, Hormones, and Neurotransmitters	82
COVID-19 and Depression	77
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review	75
Effect of Social Determinants of Health on Cognition and Risk of Alzheimer Disease and Related Dementias	66
Use of Real-world Data for New Drug Applications and Line Extensions	63
Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote	57
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in	55
Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey	53
Association Between Clinical Manifestations and Prognosis in Patients with COVID-19	49
Breastfeeding in a Global Context: Epidemiology, Impact, and Future Directions	44
Neuromodulation for the Treatment of Epilepsy: A Review of Current Approaches and Future Directions	40
Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial	40
Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review	39
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in	38
Nonalcoholic Fatty Liver Disease: A Global Perspective	38
Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World	36
A Narrative Review of Sex Differences in Eating Disorders: Is There a Biological Basis?	34
Review of Transcranial Magnetic Stimulation in Epilepsy	34
Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review	34
Current Therapeutic Approaches to Anorexia Nervosa: State of the Art	32
Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study	32
Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke	31
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial	31

Maternal Psychological Distress and Lactation and Breastfeeding Outcomes: a Narrative Review	31
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy	28
The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug-Resistant Organisms	27